Elekta Unity MR-linac receives Medical Device License from Health Canada

By News Release

 

The Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received a Medical Device License from Health Canada, clearing the technology for commercial sales in Canada.

“We are pleased to have achieved this important milestone toward making Elekta Unity available in Canada and expect that this important new treatment option will become available to patients later this year, subsequent to receiving a service license from the Canadian Nuclear Safety Commission,” said Richard Hausmann, Elekta President and CEO. “Researchers and clinicians from the Odette Cancer Centre at Sunnybrook Health Sciences Centre and Princess Margaret Cancer Centre have played critical roles in developing and evaluating this transformative technology, and we look forward to the day when their patients and other Canadian cancer patients will have access to this transformative approach to radiation therapy.”

As described in a company release, the Elekta Unity combines a high-field 1.5T Philips MRI scanner with a best-in-class linear accelerator and breakthrough real-time dose replanning software that are fully integrated to enable online adaptive radiotherapy and real-time target monitoring. It provides the ability to reshape the dose based on daily changes in shape, size and position of the tumor and surrounding healthy anatomy and then enables accurate dose delivery with real-time visualization of the tumor.

Back To Top

Elekta Unity MR-linac receives Medical Device License from Health Canada.  Appl Rad Oncol. 

By News Release| March 25, 2019
Categories:  Section|Technologies

About the Author

News Release

News Release

 



Copyright © Anderson Publishing, Ltd

 2019
    Agility CMS